Recent research highlights that MIC13-linked cristae disruption leads to metabolic failure and early fibrotic remodeling in mitochondrial liver disease. This discovery could pave the way for targeted therapies in affected patients.
mic13 linked cristae disruption causes metabolic failure and early fibrotic remodelling in mitochondrial liver disease
Original title: “MIC13-linked cristae disruption causes metabolic failure and early fibrotic remodelling in mitochondrial liver disease.”